University of Otago: Research Finds Common Type-2 Diabetes Drug Metformin Reduces Risk of Prostate Cancer
June 23, 2026
June 23, 2026
DUNEDIN, New Zealand, June 23 (TNSjou) -- The University of Otago issued the following news release:
* * *
Surprising effect of common drug found
A drug commonly used to treat type-2 diabetes has the added bonus of reducing the risk of prostate cancer, new research has found.
For the study, published in Rejuvenation Research, researchers conducted a literature review of research from the past 10 years, covering 2.25 million patients with type-2 . . .
* * *
Surprising effect of common drug found
A drug commonly used to treat type-2 diabetes has the added bonus of reducing the risk of prostate cancer, new research has found.
For the study, published in Rejuvenation Research, researchers conducted a literature review of research from the past 10 years, covering 2.25 million patients with type-2 . . .